Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219693 · ClinicalTrials.gov registry record
QuantaFlo HD Clinical Validation Study
A clinical trial of To Assess Cardiovascular Function, sponsored by Semler Scientific.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT07219693: Recruiting study of To Assess Cardiovascular Function, sponsored by Semler Scientific.
NCT07219693 is a study of To Assess Cardiovascular Function that is actively recruiting participants, run by Semler Scientific. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219693, a study of To Assess Cardiovascular Function, is actively recruiting participants, sponsored by Semler Scientific.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this validation protocol is to assess cardiovascular function through transthoracic echocardiography ("Echo") measurements and the QuantaFlo HD test measuring blood flow at the finger during a forced expiration ("FE"). The study examines whether Echo-measured GLS values greater than -16% correlate with abnormal responses during FE as measured by QuantaFlo HD.
Primary Outcome
Evaluate the sensitivity and specificity of QuantaFlo HD test results to GLS findings.
Conditions Studied
Interventions
- DEVICE QuantaFlo HD
Study Locations (1)
Arizona
- Pima Heart and Vascular - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-08-21 |
| Est. Completion | 2026-06-30 |
What NCT07219693 shows while recruiting
NCT07219693 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with To Assess Cardiovascular Function appearing as the primary indexed condition, and to 1 intervention - of which QuantaFlo HD is the first listed.
NCT07219693 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT07219693 about?
NCT07219693 is a clinical study titled "QuantaFlo HD Clinical Validation Study". The primary aim of this validation protocol is to assess cardiovascular function through transthoracic echocardiography ("Echo") measurements and the QuantaFlo HD test measuring blood flow at the finger during a forced expiration ("FE"). The study examines whether Echo-measured GLS values greater th...
What is the current status of trial NCT07219693?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2025-08-21. Estimated completion is 2026-06-30.
What conditions does trial NCT07219693 study?
This clinical trial studies the following conditions: To Assess Cardiovascular Function.
What interventions are being tested in trial NCT07219693?
The interventions under investigation include: QuantaFlo HD (DEVICE).
Who is sponsoring clinical trial NCT07219693?
This trial is sponsored by Semler Scientific, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219693 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI